Alpha-Naphthylisocyanate

Alpha-Naphthylisocyanate

SCHEMBL5505170

O=C=NCCc1ccccc1.O=C=Nc1cccc2ccccc12

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.45
CYP1A2 P05177 2/20 0.45
ALDH1A1 P00352 2/20 0.45
ABCB11 O95342 1/20 0.45
NR3C1 P04150 1/20 0.45
ADRA2A P08913 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
ADRA2C P18825 1/20 0.45
MAOA P21397 1/20 0.45
DRD1 P21728 1/20 0.45
SLC6A4 P31645 1/20 0.45
HTR2B P41595 1/20 0.45
CCR2 P41597 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MIF P14174 3/20 0.42
TRPA1 O75762 1/20 0.42
CYP2E1 P05181 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Naphthylisocyanate SCHEMBL374 0.81 CYP1A2 (0.64) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
Alpha-Naphthylisocyanate SCHEMBL29400034 0.81 CYP1A2 (0.64) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
Alpha-Naphthylisocyanate SCHEMBL28223340 0.80 CYP3A4 (0.45) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
Alpha-Naphthylisocyanate SCHEMBL3333508 0.79 CYP1A2 (0.62) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
Phenethyl Isocyanate SCHEMBL5918 0.79 MIF (0.63) CYP3A4ALDH1A1ADRA2AHPGDALOX15
Alpha-Naphthylisocyanate SCHEMBL3338004 0.78 CYP1A2 (0.60) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
SCHEMBL9195080 0.78 CYP3A4 (0.50) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
Alpha-Naphthylisocyanate SCHEMBL27296117 0.76 CYP1A2 (0.58) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
SCHEMBL3814088 0.75 CYP3A4 (0.47) CYP3A4CYP1A2ALDH1A1ABCB11NR3C1
SCHEMBL714592 0.73 CYP1A2 (0.46) CYP1A2ALDH1A1HPGDTDP1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1754705-A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders Genentech, Inc. (US) 2007-02-21 EP claimed